South Korea may start “Coexisting with COVID-19” from next month
- EPA Announces First-Ever Regulation for “Forever Chemicals” in Drinking Water
- Kochi University pioneers outpatient bladder cancer treatment using semiconductor lasers
- ASPEN 2024: Nutritional Therapy Strategies for Cancer and Critically Ill Patients
- Which lung cancer patients can benefit from neoadjuvant immunotherapy?
- Heme Iron Absorption: Why Meat Matters for Women’s Iron Needs
- “Miracle Weight-loss Drug” Semaglutide Is Not Always Effective
South Korea may start “Coexisting with COVID-19” from next month
- Red Yeast Rice Scare Grips Japan: Over 114 Hospitalized and 5 Deaths
- Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
South Korea may start “Coexisting with COVID-19” from next month.
South Korea may take the first step of “coexisting with the COVID-19” from next month, focusing on preventing death and severe illness.
On October 1, 2021 local time, in Seoul, South Korea, people walk on the streets of South Korea under the COVID-19 epidemic. People’s Visual Information MapOn October 1, 2021 local time, in Seoul, South Korea, people walk on the streets of South Korea under the COVID-19 epidemic.
South Korea may take the first step to “coexist with the COVID-19” next month. This will be the first time the South Korean government has initiated the transformation of the epidemic prevention system since the first confirmed case of the COVID-19 in South Korea on January 20 last year.
It will shift the focus of epidemic prevention work to the management of death and critically ill patients, and relax public facilities. Restrictions on operations and private gatherings will restore daily order in stages.
According to Yonhap News Agency’s report on the 17th, Prime Minister Kim Bu-gyeom said that before deciding on the epidemic prevention response adjustment plan that day, he hoped that this would be the last time the epidemic prevention response measures were adjusted, and that daily order would be restored in stages starting from November.
As of this weekend, the inoculation rate of the COVID-19 vaccine in South Korea has reached 70%, which meets the core conditions for the transformation of the epidemic prevention system.
According to reports, the South Korean government will gradually relax restrictions on living facilities, large-scale events, and private gatherings in accordance with the vaccination rate in different periods, but the basic rules of “maintaining social distance” and wearing masks will still be maintained.
In addition, the “vaccine pass” system will also be implemented for a limited time in public facilities such as performance venues and sports fields where the risk of epidemic transmission is relatively high.
The report pointed out that although the number of new confirmed cases in a single day after the policy adjustment may reach 4,000 to 5,000, the South Korean government will still work to restore daily order.
As the rate of severely ill patients has fallen sharply, the government has also formulated a home treatment plan. If oral specific drugs are officially released, the rate of home treatment patients will further increase.
However, the biggest variable in restoring daily order is the emergence of new mutant strains, and it is also very important to formulate an epidemic prevention plan to deal with unpredictable emergencies.
If there is a mutated virus with fast spreading speed, high vaccine tolerance and high fatal rate in the future, and a pandemic that is far beyond the tolerance of society continues, it is necessary to take additional preventive measures.
South Korea may start “Coexisting with COVID-19” from next month
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
